Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 12/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9650387 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9CA1CA2 | |
| SCHEMBL3661089 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9CA1CA2 | |
| SCHEMBL8122592 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 | |
| SCHEMBL200229 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9CA1CA2 | |
| SCHEMBL15731847 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 | |
| SCHEMBL8122591 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 | |
| SCHEMBL9969913 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 | |
| SCHEMBL6686776 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 | |
| SCHEMBL13887116 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9CA1CA2 | |
| SCHEMBL15428876 | 0.82 | DPP4 (0.44) | DPP4DPP8DPP9TERTDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101657211-A | Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity | AETERNA ZENTARIS GMBH DE | 2010-02-24 | — | — | CN | claimed |
| CN-101657211-A | Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity | AETERNA ZENTARIS GMBH DE | 2010-02-24 | — | — | CN | disclosed |
| US-5153274-A | Reacting a carboxylated acrylonitrile-butadiene polymer and the resin product of a diamine or dihydrazide and an N,N'-bisimide of an unsaturated carboxylic acid; adhesives; composites; toughness | THE SECRETARY OF STATE FOR DEFENCE IN HER MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1992-10-06 | — | — | US | disclosed |
| US-5087681-A | Thermosetting composition; crosslinked polyimide matrix | SECRETARY OF STATE FOR DEFENCE IN HER MAJESTY'S GOVERNMENT OF UNITED KINGDOM (GB) | 1992-02-11 | — | — | US | disclosed |
| EP-0165812-B1 | THERMOSETTING IMIDE RESIN COMPOSITIONS | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1988-11-09 | — | — | EP | disclosed |
| EP-0131027-B1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1986-12-17 | — | — | EP | disclosed |
| EP-0165812-A2 | Thermosetting imide resin compositions | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1985-12-27 | — | — | EP | disclosed |
| EP-0131027-A1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS. | SECR DEFENCE BRIT (GB) | 1985-01-16 | — | — | EP | disclosed |
| WO-1984002528-A1 | CURABLE THERMOSETTING PREPOLYMERISED IMIDE RESIN COMPOSITIONS | SECR DEFENCE BRIT (GB) | 1984-07-05 | — | — | WO | disclosed |
| US-4211861-A | N,N*-BISIMIDE | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1980-07-08 | — | — | US | disclosed |